This article was updated on Friday, October 15 at 8:04 p.m.
The U.S. Centers for Disease Control and Prevention (CDC) says it will accept international travellers vaccinated with mixed doses of any FDA or WHO-approved COVID-19 vaccines, Reuters is reporting.
Last week, the U.S. said it will accept international travellers who received COVID-19 vaccines authorized by U.S. regulators or the World Health Organization (WHO)
This includes six brands of vaccines: Oxford/AstraZeneca (including its Indian-made counterpart, Covishield), Johnson and Johnson, Moderna, Pfizer/BionTech, Sinopharm and Sinovac.
But until now, it hasn't been clear if whether mixed vaccinations would be accepted in the U.S. system.
According to a CDC spokesperson, the U.S. health agency is going to update its guidance and accept mixed doses.
“Today CDC added language to our fully vaccinated guidance about the interpretation of vaccine records, including which vaccinations and what type will be accepted to be considered fully vaccinated,” a statement from the disease control agency said Friday (Oct. 15).
“It confirmed that individuals who have any combination of two doses of an FDA approved/authorized or WHO emergency use listed COVID-19 two-dose series are considered fully vaccinated.”
This will come as very good news to the 3.88 million fully vaccinated Canadians who received two different kinds of COVID-19 vaccines (and that number doesn't even include people from Quebec where data on mixed vaccines is unavailable).
"While CDC has not recommended mixing types of vaccine in a primary series, we recognize that this is increasingly common in other countries so should be accepted for the interpretation of vaccine records," a CDC spokeswoman told Reuters.
The White House said Friday that both its land and air border will reopen for fully vaccinated foreign nationals on Nov. 8.
"This policy is guided by public health, stringent, and consistent," said White House Assistant Press Secretary Kevin Munoz on his Twitter account.
Canada updated its vaccination guidelines in June, saying that mixing COVID-19 vaccine doses, based on the available research, was safe.
This is a developing story.